<?xml version="1.0" encoding="iso-8859-1" standalone="no"?>
<!DOCTYPE GmsArticle SYSTEM "http://www.egms.de/dtd/2.0.34/GmsArticle.dtd">
<GmsArticle xmlns:xlink="http://www.w3.org/1999/xlink">
  <MetaData>
    <Identifier>25rhk007</Identifier>
    <IdentifierDoi>10.3205/25rhk007</IdentifierDoi>
    <IdentifierUrn>urn:nbn:de:0183-25rhk0072</IdentifierUrn>
    <ArticleType>Meeting Abstract</ArticleType>
    <TitleGroup>
      <Title language="en">AI-Assisted ANA Immunofluorescence Testing: High Specificity compared to the Gold Standard VI-IIFT</Title>
    </TitleGroup>
    <CreatorList>
      <Creator>
        <PersonNames>
          <Lastname>Mayr</Lastname>
          <LastnameHeading>Mayr</LastnameHeading>
          <Firstname>Sarah</Firstname>
          <Initials>S</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Asklepios Klinik Bad Abbach, Rheumatologie, Bad Abbach</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Dollinger</Lastname>
          <LastnameHeading>Dollinger</LastnameHeading>
          <Firstname>Margit</Firstname>
          <Initials>M</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Asklepios Klinik Bad Abbach, Rheumatologie, Bad Abbach</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Ehrenstein</Lastname>
          <LastnameHeading>Ehrenstein</LastnameHeading>
          <Firstname>Boris</Firstname>
          <Initials>B</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Asklepios Klinik Bad Abbach, Rheumatologie, Bad Abbach</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>G&#252;nther</Lastname>
          <LastnameHeading>G&#252;nther</LastnameHeading>
          <Firstname>Florian</Firstname>
          <Initials>F</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Asklepios Klinik Bad Abbach, Rheumatologie, Bad Abbach</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Knies</Lastname>
          <LastnameHeading>Knies</LastnameHeading>
          <Firstname>Christine</Firstname>
          <Initials>C</Initials>
        </PersonNames>
        <Address>
          <Affiliation>medac GmbH, Wedel</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Fleck</Lastname>
          <LastnameHeading>Fleck</LastnameHeading>
          <Firstname>Martin</Firstname>
          <Initials>M</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Asklepios Klinik Bad Abbach, Rheumatologie, Bad Abbach</Affiliation>
          <Affiliation>Uniklinikum Regensburg, Innere Medizin I, Regensburg</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
    </CreatorList>
    <PublisherList>
      <Publisher>
        <Corporation>
          <Corporatename>German Medical Science GMS Publishing House</Corporatename>
        </Corporation>
        <Address>D&#252;sseldorf</Address>
      </Publisher>
    </PublisherList>
    <SubjectGroup>
      <SubjectheadingDDB>610</SubjectheadingDDB>
    </SubjectGroup>
    <DatePublishedList>
      <DatePublished>20250917</DatePublished>
    </DatePublishedList>
    <Language>engl</Language>
    <License license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
      <AltText language="en">This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License.</AltText>
      <AltText language="de">Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung).</AltText>
    </License>
    <SourceGroup>
      <Meeting>
        <MeetingId>M0627</MeetingId>
        <MeetingSequence>007</MeetingSequence>
        <MeetingCorporation>Deutsche Gesellschaft f&#252;r Rheumatologie</MeetingCorporation>
        <MeetingCorporation>Deutsche Gesellschaft f&#252;r Orthop&#228;dische Rheumatologie</MeetingCorporation>
        <MeetingName>53. Kongress der Deutschen Gesellschaft f&#252;r Rheumatologie (DGRh), 39. Jahrestagung der Deutschen Gesellschaft f&#252;r Orthop&#228;dische Rheumatologie (DGORh)</MeetingName>
        <MeetingTitle>Deutscher Rheumatologiekongress 2025</MeetingTitle>
        <MeetingSession>Diagnostik &#38; Bildgebung</MeetingSession>
        <MeetingCity>Wiesbaden</MeetingCity>
        <MeetingDate>
          <DateFrom>20250917</DateFrom>
          <DateTo>20250920</DateTo>
        </MeetingDate>
      </Meeting>
    </SourceGroup>
    <ArticleNo>DI.10</ArticleNo>
  </MetaData>
  <OrigData>
    <TextBlock name="Text" linked="yes">
      <MainHeadline>Text</MainHeadline><Pgraph><Mark1>Background:</Mark1> Autoantibodies against cell nuclei (ANA) play a crucial role in diagnosing autoimmune diseases, particularly connective tissue diseases. The gold standard for ANA detection is the visual interpretation of indirect immunofluorescence testing (VI-IIFT) using human epithelial (HEp-2) cells <TextLink reference="1"></TextLink>. Since this method is time-consuming and labor-intensive, research is focusing on automated evaluation systems utilizing artificial intelligence (AI).</Pgraph><Pgraph><Mark1>Methods: </Mark1>A total of 143 consecutive serum samples from routine clinical care were collected from patients visiting our tertiary Rheumatology center, and included in the study. For these samples, both VI-IIFT (with ANA HEp-2 cells from AESKU, Germany) and an AI-based method for automated evaluation of processed immunofluorescence slides (akiron<Superscript>&#174;</Superscript> NEO by Medipan) were performed <TextLink reference="2"></TextLink>. Titer levels and the International Consensus on ANA Patterns (ICAP) classification were analyzed. The primary outcomes included sensitivity, specificity, and concordance of titer concentration.</Pgraph><Pgraph><Mark1>Results: </Mark1>Of the 143 analyzed samples, VI-IIFT, as the gold standard, classified 40 samples (28&#37;) as negative and 102 (72&#37;) as positive, whereas the automated interpretation identified 69 samples (48.3&#37;) as negative and 74 (51.7&#37;) as positive. When compared to the reference standard, the AI-based method showed no false-positive results, yielding a specificity of 100&#37;. However, its sensitivity was limited to 71.8&#37;.</Pgraph><Pgraph>The ICAP classification was most reliable for AC-3, where specificity reached 100&#37;. Notably, titer levels in the automated evaluations were frequently assessed at higher values than in the gold standard interpretation.</Pgraph><Pgraph><Mark1>Conclusion: </Mark1>Our study demonstrated a specificity of 100&#37; for AI-assisted ANA interpretation compared to the gold standard VI-IIFT. However, sensitivity was only 71.8&#37;, indicating a need for further optimization. Further research and algorithm refinement (e.g., improved pattern recognition and titer calibration) are necessary to enhance sensitivity and support its future implementation as a reliable screening method.</Pgraph><Pgraph><Mark1>Disclosures: </Mark1>The study was supported by Medipan, which provided the akiron<Superscript>&#174;</Superscript> NEO analyzer.</Pgraph></TextBlock>
    <References linked="yes">
      <Reference refNo="1">
        <RefAuthor>Alsuwaidi M</RefAuthor>
        <RefAuthor>Dollinger M</RefAuthor>
        <RefAuthor>Fleck M</RefAuthor>
        <RefAuthor>Ehrenstein B</RefAuthor>
        <RefTitle>The Reliability of a Novel Automated System for ANA Immunofluorescence Analysis in Daily Clinical Practice</RefTitle>
        <RefYear>2016</RefYear>
        <RefJournal>Int J Rheumatol</RefJournal>
        <RefPage>6019268</RefPage>
        <RefTotal>Alsuwaidi M, Dollinger M, Fleck M, Ehrenstein B. The Reliability of a Novel Automated System for ANA Immunofluorescence Analysis in Daily Clinical Practice. Int J Rheumatol. 2016;2016:6019268. DOI: 10.1155&#47;2016&#47;6019268</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1155&#47;2016&#47;6019268</RefLink>
      </Reference>
      <Reference refNo="2">
        <RefAuthor>Medipan &#38; GA Generic Assays</RefAuthor>
        <RefTitle></RefTitle>
        <RefYear></RefYear>
        <RefBookTitle>4450 &#8211; akiron&#174; NEO</RefBookTitle>
        <RefPage></RefPage>
        <RefTotal>Medipan &#38; GA Generic Assays. 4450 &#8211; akiron&#174; NEO. &#91;accessed 2025 Mar 16&#93;. Available from: https:&#47;&#47;www.medipan.de&#47;products&#47;akiron-neo&#47;</RefTotal>
        <RefLink>https:&#47;&#47;www.medipan.de&#47;products&#47;akiron-neo&#47;</RefLink>
      </Reference>
    </References>
    <Media>
      <Tables>
        <NoOfTables>0</NoOfTables>
      </Tables>
      <Figures>
        <NoOfPictures>0</NoOfPictures>
      </Figures>
      <InlineFigures>
        <NoOfPictures>0</NoOfPictures>
      </InlineFigures>
      <Attachments>
        <NoOfAttachments>0</NoOfAttachments>
      </Attachments>
    </Media>
  </OrigData>
</GmsArticle>